CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance beginning (in shares) at Dec. 31, 2021		76,433,151
Balance beginning at Dec. 31, 2020	$ 627,209	$ 714	$ 2,535,476	$ (1,874,199)	$ (41,806)	$ 7,024
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	183,626		183,626
Stock issued under incentive programs (in shares)		2,503,819
Stock issued under incentive programs	24,761	$ 24	68,032		(43,295)
Issuance of common stock, net of issuance costs (in shares)		2,578,967
Issuance of common stock, net of issuance costs	564,859	$ 26	564,833
Unrealized gain (loss) on marketable securities	(9)					(9)
Foreign currency translation adjustment	(8,368)					(8,368)
Net loss	(1,743,751)			(1,743,751)
Balance ending (in shares) at Dec. 31, 2020		71,350,365
Balance ending at Dec. 31, 2021	$ (351,673)	$ 764	3,351,967	(3,617,950)	(85,101)	(1,353)
Balance beginning (in shares) at Dec. 31, 2022	86,039,923	86,806,554
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 131,967		131,967
Stock issued under incentive programs (in shares)		701,005
Stock issued under incentive programs	(639)	$ 7	4,912		(5,558)
Issuance of common stock, net of issuance costs (in shares)		9,672,398
Issuance of common stock, net of issuance costs	249,230	$ 97	249,133
Foreign currency translation adjustment	(5,024)					(5,024)
Net loss	(657,939)			(657,939)
Balance ending (in shares) at Dec. 31, 2021		76,433,151
Balance ending at Dec. 31, 2022	$ (634,078)	$ 868	3,737,979	(4,275,889)	(90,659)	(6,377)
Balance beginning (in shares) at Dec. 31, 2023	139,505,770	140,506,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 85,850		85,850
Stock issued under incentive programs (in shares)		902,742
Stock issued under incentive programs	159	$ 9	1,758		(1,608)
Issuance of common stock, net of issuance costs (in shares)		52,796,797
Issuance of common stock, net of issuance costs	367,105	$ 528	366,577
Foreign currency translation adjustment	9,099					9,099
Net loss	$ (545,062)			(545,062)
Balance ending (in shares) at Dec. 31, 2022	86,039,923	86,806,554
Balance ending at Dec. 31, 2023	$ (716,927)	$ 1,405	$ 4,192,164	$ (4,820,951)	$ (92,267)	$ 2,722